March 18, 2026 · Blood · DOI: 10.1182/blood.2025031924

Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML

Listen to this summary

The authors investigate how inhibition of the lysine acetyltransferase (KAT) activity of p300/CREBBP affects transcription in acute myeloid leukemia (AML). They find that this inhibition paradoxically enhances transcription by promoting cooperative transcription factor assembly and increasing H3K27 acetylation at specific regulatory elements, particularly those associated with interferon-stimulated genes. Their findings suggest a novel therapeutic strategy that combines KAT inhibition with interferon-alpha to drive AML cell death and improve treatment outcomes.

Markus Meyerhöfer, Yawen Zhou, Aaron Gallego-Crespo, Viral Shah, Malte Andreas Behrendt, Maria Saura-Pañella, Björn Häupl, Oleksandr Todoriuk, Monika Hartmann, Matthias Klein, Catherine Wölfel, Patricia S Hähnel, Christian S Michel, Sabine Muth, Thomas Kindler, Tobias Bopp, Hansjörg Schild, Sarah J Horton, Markus P Radsak, Matthias Theobald, George S Vassiliou, Brian Jp Huntly, Michael Wm Kühn, Falk Butter, Thomas Oellerich, Daniel Sasca

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play